THE TAPE
DRTS · Medical Instruments · $1.1B

Alpha Tau Medical Ltd. Ordinary Shares

$11.97▼ −10.54%
Last close
Relative strength
96RS
of 99, against every stock▼ -1 on the month
Cooling off
Strong industry, weak stock
−9.1%
six months against Medical Instruments
52-week range
−24.2%
from the high
$3.43$15.79
Setup
blue skyplayed out
−15.2%
against the pivot at $14.11
8 days
Nov 24 · confirmed
No US GAAP filings to read.
11/16 O 14.20 H 14.41 L 11.80 Vol 2.3M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS96
vs pivot−15.17%
Tightening1.10×
Dry-up1.59×
Up/down vol-0.12
From high24%
squatfailed pokeplayed out4 of 9checks
Previous breakout stopped out ▼ −8.19% in Jun
Cooling off
Support and resistance
Support below
$11.27
-5.8% · tested 3× · last 77 sessions ago
Resistance above
$12.06
+0.8% · tested 3× · last 21 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 5.2 weeks and fell 22% from its ceiling at its deepest. The pivot is $14.11, and the stock closed 15.2% below it. Its relative strength rating is 96.

Against its industry
Strong industry, weak stockBehind its industry over one and six months while the industry is fully aligned and ahead of the S&P 500.
One month against its industry
-6.5%
Three months against its industry
-16.2%
Six months against its industry
-9.1%

Read against an equal-weighted index of Medical Instruments, which is +31.0% against the S&P 500 over six months Fully aligned.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
8
days
Earnings in 8 days
Nov 24, 2026
  1. Earningsconfirmedin 8d
    Quarterly earnings
    Nov 24, 2026
How it moves on earnings

On average 5.5% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business

No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
GappedTape · 2026-11-06
-5.2%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-04
+5.5%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-09-24
-6.3%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
12
$1,562,435 total

Sold: Levy Raphi.

Not counted above: 5 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-08-21 Levy Raphi · Chief Financial Officeroption exercise2,871$8,556
2026-08-21 Levy Raphi · Chief Financial Officersell2,871$43,073
2026-08-11 Levy Raphi · Chief Financial Officeroption exercise17,730$52,835
2026-08-11 Levy Raphi · Chief Financial Officersell17,730$248,277
2026-07-06 Levy Raphi · Chief Financial Officeroption exercise2,270$6,765
2026-07-06 Levy Raphi · Chief Financial Officersell2,270$31,782
2026-07-02 Levy Raphi · Chief Financial Officeroption exercise17,873$53,262
2026-07-02 Levy Raphi · Chief Financial Officersell17,873$232,397

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

4 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy1
Buy3
Hold1
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray
5w · 22%

The most recent of 5 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Alpha Tau Medical Ltd. Ordinary Shares (DRTS) — The Tape